FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3194076091> ?p ?o ?g. }

• W3194076091 endingPage "3431" @default.
• W3194076091 startingPage "3423" @default.
• W3194076091 abstract "Benign prostatic hyperplasia (BPH) is a common micturition disorder in middle-aged and elderly males, and it is one of the most common urology-related diseases worldwide. However, standard therapeutic drugs (α1-receptor blockers + 5α reductase inhibitors) do not provide anti-inflammatory or anti-infective effects. The Phellodendron Bawei tablet is a proprietary Chinese medicine with anti-inflammatory and anti-infective effects. Here, we analyzed whether the combination of standard therapeutic drugs and Phellodendron Bawei tablets has more advantages than placebo with standard management in improving the lower urinary tract symptoms (LUTs), sleep quality, sexual function, and medication compliance in patients with BPH.This study was a prospective, double-blind, single-center, 6-month clinical trial in patients with BPH. Male patients, 45-75 years old, a history of moderate-to-severe BPH/LUTs for more than 6 months, moderate-to-severe LUTs [International Prostate Symptom Score (IPSS) ≥8], maximum urine flow rate (Qmax) of <15 mL/s, and prostate volume (PV) of >30 mL. All patients were randomly divided into two cohorts at baseline. The standard management (SM) group was treated with tamsulosin + finasteride + placebo, while the experimental group was treated with tamsulosin + finasteride + Phellodendron Bawei tablets. The clinical indicators were as follows: Age, body mass index (BMI), blood prostate-specific antigen (PSA), PV, Qmax, IPSS; IPSS voiding subscore (IPSS-V), IPSS storage subscore (IPSS-S), and IPSS quality of life (IPSS-QOL)], five-item version of the International Index of Erectile Function (IEFF-5) score, Athens Insomnia Scale (AIS) score, and the Medication Adherence Questionnaire (MAQ). And adverse drug reactions were observed. Student's t-test was used to analyze results.We randomly divided 120 patients into two groups, with 60 patients in each group, and a total of 105 patients completed the study. IPSS-S (P=0.027) and AIS scores (P<0.001) improved more significantly in the Phellodendron Bawei tablets + SM group, and the MAQ score in this group was lower (P=0.003).Phellodendron Bawei tablets combined with α1-receptor blockers and 5α-reductase inhibitors can improve lower urinary tract symptoms associated with urine storage, sleep quality, and medication compliance in patients with benign prostatic hyperplasia compared to placebo with standard management.Chinese Clinical Trial Registry ChiCTR2100046463." @default.
• W3194076091 created "2021-08-30" @default.
• W3194076091 creator A5011877804 @default.
• W3194076091 creator A5018014052 @default.
• W3194076091 creator A5018707954 @default.
• W3194076091 creator A5039589213 @default.
• W3194076091 creator A5040582111 @default.
• W3194076091 creator A5052504393 @default.
• W3194076091 creator A5076768386 @default.
• W3194076091 creator A5091491998 @default.
• W3194076091 date "2021-08-01" @default.
• W3194076091 modified "2023-09-23" @default.
• W3194076091 title "A randomized placebo-controlled study: Phellodendron Bawei tablets combined with standard management can improve storage symptoms, sleep quality, and medication compliance in patients with benign prostatic hyperplasia compared to placebo with standard management" @default.
• W3194076091 cites W1501721559 @default.
• W3194076091 cites W1984101700 @default.
• W3194076091 cites W1995499417 @default.
• W3194076091 cites W2058677706 @default.
• W3194076091 cites W2073875274 @default.
• W3194076091 cites W2081597080 @default.
• W3194076091 cites W2088829592 @default.
• W3194076091 cites W2183160060 @default.
• W3194076091 cites W2212363593 @default.
• W3194076091 cites W2291415130 @default.
• W3194076091 cites W2341767486 @default.
• W3194076091 cites W2476720412 @default.
• W3194076091 cites W2530572953 @default.
• W3194076091 cites W2605052861 @default.
• W3194076091 cites W2613945463 @default.
• W3194076091 cites W2732066871 @default.
• W3194076091 cites W2753211301 @default.
• W3194076091 cites W2805807388 @default.
• W3194076091 cites W2885082013 @default.
• W3194076091 cites W2913542019 @default.
• W3194076091 cites W2926929482 @default.
• W3194076091 cites W2953730417 @default.
• W3194076091 cites W2963027350 @default.
• W3194076091 cites W2963412981 @default.
• W3194076091 cites W2969000266 @default.
• W3194076091 cites W2980437507 @default.
• W3194076091 cites W2980786840 @default.
• W3194076091 cites W2989625686 @default.
• W3194076091 cites W2998444706 @default.
• W3194076091 cites W3014024402 @default.
• W3194076091 cites W3015082124 @default.
• W3194076091 cites W3045644757 @default.
• W3194076091 cites W3061378979 @default.
• W3194076091 cites W3084365116 @default.
• W3194076091 cites W4206042557 @default.
• W3194076091 doi "https://doi.org/10.21037/tau-21-588" @default.
• W3194076091 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8421819" @default.
• W3194076091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34532267" @default.
• W3194076091 hasPublicationYear "2021" @default.
• W3194076091 type Work @default.
• W3194076091 sameAs 3194076091 @default.
• W3194076091 citedByCount "2" @default.
• W3194076091 countsByYear W31940760912023 @default.
• W3194076091 crossrefType "journal-article" @default.
• W3194076091 hasAuthorship W3194076091A5011877804 @default.
• W3194076091 hasAuthorship W3194076091A5018014052 @default.
• W3194076091 hasAuthorship W3194076091A5018707954 @default.
• W3194076091 hasAuthorship W3194076091A5039589213 @default.
• W3194076091 hasAuthorship W3194076091A5040582111 @default.
• W3194076091 hasAuthorship W3194076091A5052504393 @default.
• W3194076091 hasAuthorship W3194076091A5076768386 @default.
• W3194076091 hasAuthorship W3194076091A5091491998 @default.
• W3194076091 hasBestOaLocation W31940760911 @default.
• W3194076091 hasConcept C121608353 @default.
• W3194076091 hasConcept C126322002 @default.
• W3194076091 hasConcept C126894567 @default.
• W3194076091 hasConcept C142724271 @default.
• W3194076091 hasConcept C204787440 @default.
• W3194076091 hasConcept C27081682 @default.
• W3194076091 hasConcept C2775871022 @default.
• W3194076091 hasConcept C2775874879 @default.
• W3194076091 hasConcept C2776235491 @default.
• W3194076091 hasConcept C2776245837 @default.
• W3194076091 hasConcept C2776547966 @default.
• W3194076091 hasConcept C2777562237 @default.
• W3194076091 hasConcept C2779478474 @default.
• W3194076091 hasConcept C2780542891 @default.
• W3194076091 hasConcept C2781210498 @default.
• W3194076091 hasConcept C2983189541 @default.
• W3194076091 hasConcept C71924100 @default.
• W3194076091 hasConcept C98274493 @default.
• W3194076091 hasConceptScore W3194076091C121608353 @default.
• W3194076091 hasConceptScore W3194076091C126322002 @default.
• W3194076091 hasConceptScore W3194076091C126894567 @default.
• W3194076091 hasConceptScore W3194076091C142724271 @default.
• W3194076091 hasConceptScore W3194076091C204787440 @default.
• W3194076091 hasConceptScore W3194076091C27081682 @default.
• W3194076091 hasConceptScore W3194076091C2775871022 @default.
• W3194076091 hasConceptScore W3194076091C2775874879 @default.
• W3194076091 hasConceptScore W3194076091C2776235491 @default.
• W3194076091 hasConceptScore W3194076091C2776245837 @default.
• W3194076091 hasConceptScore W3194076091C2776547966 @default.
• W3194076091 hasConceptScore W3194076091C2777562237 @default.
• W3194076091 hasConceptScore W3194076091C2779478474 @default.
• W3194076091 hasConceptScore W3194076091C2780542891 @default.

• next